Brucella induces STING-mediated Guanylate-Binding Protein expression and Unfolded Protein Response: Balancing Bacterial Elimination, Inflammation and Disease
Brucella induces STING-mediated Guanylate-Binding Protein expression and Unfolded Protein Response: Balancing Bacterial Elimination, Inflammation and Disease
批准号:
9928608
负责人:
Glen N. Barber
金额:
$14.78万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-01-20 至 2026-04-30
关键词:
ATF6 geneAcidsAdjuvantAffectAnimalsAnti-Bacterial AgentsBacterial DNABinding ProteinsBiological Response ModifiersBrazilBrucellaBrucella abortusBrucella abortus infectionBrucellosisCASP1 geneCaspaseCattleCell LineCellsCellular biologyCessation of lifeChromosome 3CytosolDNADataDiseaseEconomic BurdenEquilibriumFlow CytometryGBP1 geneGenetically Engineered MouseGoalsHealth Care CostsHost resistanceHumanITGAX geneImmuneImmune responseImmunityInfectionInfection ControlInflammasomeInflammationInnate Immune ResponseInterferonsInterleukin-1 betaInterleukin-4Knockout MiceLigandsLightMeasuresMediatingMetabolicMicrobiologyMitochondriaMusNatural ImmunityPathogenesisPathway interactionsPhenotypeProductionProductivityPropertyProteinsQuality of lifeResearchResearch PersonnelResistanceResistance to infectionRespirationRoleSecureSmall Interfering RNASocial ImpactsSuccinatesTestingVaccinesVacuoleZoonosesbasechronic infectionconditional knockoutdisorder controlexperimental studyglucose uptakeguanylateimmune activationin vivoinhibitor/antagonistinnate immune pathwaysmacrophagepathogenpreventprotein expressionreceptorresponsesensortauroursodeoxycholic acidtranscription factortransmission processvaccine efficacyvaccine-induced immunity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1 Summary
2 Brucellosis is one of the world’s most frequent zoonotic diseases with over 500,000
3 new human infections every year. Human brucellosis in Brazil represents an additional
4 economic burden due to health care costs and has a major social impact due to
5 decreased productivity and quality of life and occasionally incapacitation or death.
6 Brucella abortus strain 19 vaccine is the principal vaccine used to prevent transmission
7 of brucellosis from cattle to humans worldwide and in Brazil and it is not a select agent.
8 The mechanisms that mediate protection by strain 19 are poorly understood. Host
9 mechanisms of innate immunity induced by the vaccine that control infection remain
10 obscure. Additionally, the vaccine contains several properties that are inhibitory to host
11 immunity. We have demonstrated that B. abortus, bacterial DNA and LPS leads to
12 inflammasome activation via STING/GBP (guanylate-binding protein) axis that limits
13 Brucella replication. In contrast, B. abortus induces the Unfolded Protein Response
14 (UPR) that favors Brucella survival in the host. Therefore, our long-term goal is to
15 resolve the black box of how Brucella activates innate immune components that
16 results in host resistance versus bacterial subversion of the immune response.
17 Based on these compelling preliminary data, we propose to test the central hypothesis
18 that Brucella abortus strain 19 activates protective innate immune mediators via
19 STING/GBP pathway and triggers the UPR to secure intracellular replication. Our
20 specific aims are: 1) To define which STING-mediated guanylated-binding proteins
21 (GBPs) are important to release bacterial DNA and LPS into host cells to activate
22 inflammasome receptors; 2) To determine whether the Unfolded Protein
23 Response (UPR) induced by Brucella regulates macrophage polarization to
24 facilitate bacterial persistence; 3) To determine whether the transcription factor
25 HIF-1α-dependent metabolic changes in macrophages induced by Brucella affect
26 inflammasome activation and bacterial clearance. We believe that our approach will
27 shed light on the mechanisms of immunity and/or pathogenesis of this important
28 human and animal pathogen. Finally, the investigators on this proposal have a strong
29 track record in brucellosis research and a unique combination of key expertise in
30 microbiology, innate immunity and cell biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of A HTLV-1 Vaccine
-
批准号:10363730
-
项目类别:
-
资助金额:$58.87万
-
财政年份:2021
-
负责人:Glen N. Barber
-
依托单位:
Development of A HTLV-1 Vaccine
-
批准号:10209750
-
项目类别:
-
资助金额:$62.37万
-
财政年份:2021
-
负责人:Glen N. Barber
-
依托单位:
Development of A HTLV-1 Vaccine
-
批准号:10582706
-
项目类别:
-
资助金额:$58.37万
-
财政年份:2021
-
负责人:Glen N. Barber
-
依托单位:
Brucella induces STING-mediated Guanylate-Binding Protein expression and Unfolded Protein Response: Balancing Bacterial Elimination, Inflammation and Disease
-
批准号:10401750
-
项目类别:
-
资助金额:$14.49万
-
财政年份:2016
-
负责人:Glen N. Barber
-
依托单位:
Brucella induces STING-mediated Guanylate-Binding Protein expression and Unfolded Protein Response: Balancing Bacterial Elimination, Inflammation and Disease
-
批准号:10617266
-
项目类别:
-
资助金额:$14.48万
-
财政年份:2016
-
负责人:Glen N. Barber
-
依托单位:
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
-
批准号:9150544
-
项目类别:
-
资助金额:$33.24万
-
财政年份:2015
-
负责人:Glen N. Barber
-
依托单位:
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
-
批准号:9752480
-
项目类别:
-
资助金额:$32.49万
-
财政年份:2015
-
负责人:Glen N. Barber
-
依托单位:
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
-
批准号:9339626
-
项目类别:
-
资助金额:$33.24万
-
财政年份:2015
-
负责人:Glen N. Barber
-
依托单位:
The role of STING in innate immunity
-
批准号:8892552
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2014
-
负责人:Glen N. Barber
-
依托单位:
Evaluation of Novel DExD/H Helicases in Innate Immune Signaling
-
批准号:8066287
-
项目类别:
-
资助金额:$36.71万
-
财政年份:2009
-
负责人:Glen N. Barber
-
依托单位:
Host Defense Regulation and Viral Oncogenesis
-
批准号:7915294
-
项目类别:
-
资助金额:$116.67万
-
财政年份:2009
-
负责人:Glen N. Barber
-
依托单位:
Evaluation of Novel DExD/H Helicases in Innate Immune Signaling
-
批准号:8260285
-
项目类别:
-
资助金额:$36.68万
-
财政年份:2009
-
负责人:Glen N. Barber
-
依托单位:
Innate Intracellular Mechanisms
-
批准号:7847608
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2009
-
负责人:Glen N. Barber
-
依托单位:
Regulation of Innate Immune Responses
-
批准号:7726080
-
项目类别:
-
资助金额:$30.5万
-
财政年份:2009
-
负责人:Glen N. Barber
-
依托单位:
Administration Core
-
批准号:7726086
-
项目类别:
-
资助金额:$17.07万
-
财政年份:2009
-
负责人:Glen N. Barber
-
依托单位:
Innate Intracellular Mechanisms
-
批准号:7389401
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2009
-
负责人:Glen N. Barber
-
依托单位:
Evaluation of Novel DExD/H Helicases in Innate Immune Signaling
-
批准号:7679882
-
项目类别:
-
资助金额:$36.39万
-
财政年份:2009
-
负责人:Glen N. Barber
-
依托单位:
Host Defense Regulation and Viral Oncogenesis
-
批准号:8120443
-
项目类别:
-
资助金额:$110.76万
-
财政年份:2009
-
负责人:Glen N. Barber
-
依托单位:
Host Defense Regulation and Viral Oncogenesis
-
批准号:7694643
-
项目类别:
-
资助金额:$116.2万
-
财政年份:2009
-
负责人:Glen N. Barber
-
依托单位:
Evaluation of Novel DExD/H Helicases in Innate Immune Signaling
-
批准号:7802839
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2009
-
负责人:Glen N. Barber
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: